Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
University of North Carolina at Chapel Hill · University of North Carolina Health Care · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
243
total citations
- FWCI
- 47.56
- Percentile
- 100%
- References
- 38
Citations per year
Authors
187- JFJames F. HowardCorresponding
University of North Carolina at Chapel Hill, University of North Carolina Health Care
- SBSaskia Bresch
Centre Hospitalier Universitaire de Nice
- AGAngela Genge
Montreal Neurological Institute and Hospital
- CHChanna Hewamadduma
Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield
- JLJohn L. Hinton
Topics & keywords
Topics
Keywords
- Myasthenia gravis
- Placebo
- Medicine
- Double blind
- Phase (matter)
- Anesthesia
- Internal medicine
- Alternative medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.